C. Morin et al., TRANSCRIPTIONAL REGULATION OF PRE-PRO-ENDOTHELIN-1 GENE BY GLUCOCORTICOIDS IN VASCULAR SMOOTH-MUSCLE CELLS, Biochemical and biophysical research communications, 244(2), 1998, pp. 583-587
Endothelin is a potent vasoactive peptide involved in the maintenance
of vascular tone and in pathophysiological states. Endothelin-l synthe
sis is controlled at the transcriptional level, We report that glucoco
rticoids increase the pre-pro-endothelin-l gene transcription rate in
vascular smooth muscle cells. The effect of glucocorticoids is dose-de
pendent (EC50 similar to 2-3 nM) and completely blocked by co-incubati
on with the glucocorticoid antagonist RU 38486. The rise in pp-Et-l st
eady state mRNA levels is rapid and transient with a maximal three-fol
d stimulation within one hour of glucocorticoid administration. Glucoc
orticoid treatment does not affect the half-life of pre-pro-endothelin
-1 mRNA as shown by actinomycin D studies. Furthermore, cycloheximide
treatment concomitantly with RU 28362 did not reverse the stimulatory
effect of glucocorticoids on pre-pro-endothelin-l mRNA levels. Nuclear
run-on analysis shows that glucocorticoids increase the transcription
rate of pre-pro-endothelin-l. Our results suggest a role for glucocor
ticoids in the regulation of biosynthesis and action of this important
vasoactive peptide in vascular smooth muscle cells. (C) 1998 Academic
Press.